New COVID-19 treatment study shows 100% of patients "virologically cured" with drug combination

By Pierre Little

The Méditerranée Infection University Hospital Institute in Marseille in France have published their open-label non-randomized clinical trial on COVID-19 treatment using hydroxychloroquine and azithromycin.  This would seem to be saying it is a cure for the infection in some cases.  Hydroxychloroquine sold as Plaquenil is used for malaria treatment and Rheumatoid Arthritis. 

Bloomberg is reporting that Apotex is donating 250,000 doses to front-line medical staff, doctors and nurses.

We have published an early report on this drug March 17. A Possible Effective Treatment for Coronavirus (COVID-19)

The study says:

100% of patients treated with hydroxychloroquine and azithromycin combination were virologically cured comparing with 57.1% in patients treated with hydroxychloroquine only, and 12.5% in the control group... 


We therefore recommend that COVID-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of COVID-19 in the world.

Open-label non-randomized clinical trial can be read online here:

Recent Anecdotal Evidence

Related Posts
Future Uncertain for Former Chinese Restaurant Building
Calais Knights of Columbus Crown Local Free Throw Champions
No More Clipping Box Tops--Just Scan Receipt for Schools